Doctrine of Equivalents After VLSI Technology Decision: Navigating DOE Amid Tight Policing; Avoiding Pitfalls
Recording of a 90-minute premium CLE video webinar with Q&A
This CLE webinar will guide patent counsel on the doctrine of equivalents both generally and in the wake of the Federal Circuit's opinion in VLSI Technology L.L.C. v. Intel Corp., No. 2022-1906 (Fed. Cir. Dec. 4, 2023). The panel will discuss the doctrine of equivalents and its exceptions as well as how patentees can leverage the doctrine of equivalents despite the court's tightening reins on the doctrine. It will also offer best practices for prosecuting claims to minimize limitations on or narrowing of the scope of equivalents. The panel will also discuss strategies that defendants can employ to counter claims of infringement under the doctrine of equivalents.
Outline
- VLSI and implications of the decision
- Doctrine of equivalents and exceptions
- Issues that could reduce the likelihood of proving infringement by the doctrine of equivalents
- Best practices for drafting and prosecuting claims to minimize estoppel-preventing doctrine of equivalents arguments
Benefits
The panel will review these and other important issues:
- Implications of the Federal Circuit's VLSI decision
- Patentee-side strategies for navigating the pitfalls of the doctrine of equivalents
- Strategies for defending against claims of infringement under the doctrine of equivalents
Faculty
Mark J. Feldstein, Ph.D.
Partner
Finnegan Henderson Farabow Garrett & Dunner
Dr. Feldstein focuses on U.S. district court litigation, primarily concerning the enforcement of U.S. patent rights and... | Read More
Dr. Feldstein focuses on U.S. district court litigation, primarily concerning the enforcement of U.S. patent rights and trade secret issues, and post-grant trial proceedings at the USPTO, including inter partes review (IPR) and post grant review (PGR). He maintains an active patent prosecution practice, preparing and prosecuting U.S. patent applications on behalf of domestic and foreign clients. He also provides opinions and strategic guidance to clients on infringement, validity, enforceability, and clearance matters. His practice encompasses a range of technologies, including pharmaceuticals, biochemistry, polymers, small molecule chemistry, optics, and medical and analytic devices.
Close-
CloseBenjamin R. Schlesinger
Partner
Finnegan Henderson Farabow Garrett & Dunner
Mr. Schlesinger, managing partner of the firm’s Atlanta office, is a registered patent attorney, focusing on... | Read More
Mr. Schlesinger, managing partner of the firm’s Atlanta office, is a registered patent attorney, focusing on patent litigation and client counseling in the electrical and computer technology fields. He practices before U.S. district courts, state courts, and the U.S. International Trade Commission (ITC).
CloseDaniel C. Tucker
Partner
Finnegan Henderson Farabow Garrett & Dunner
Mr. Tucker focuses his practice on the interplay among district court patent litigation, PTAB post-grant proceedings,... | Read More
Mr. Tucker focuses his practice on the interplay among district court patent litigation, PTAB post-grant proceedings, and Federal Circuit appeals. He has represented clients across a broad range of technologies, including wireless/cellular communications, semiconductor technology, consumer electronics, and internet services.
Close